Mesa Laboratories, Inc. (MLAB)

Market Cap	502.48M -33.7%
Revenue (ttm)	247.54M +4.1%
Net Income	3.73M
EPS	0.68
Shares Out	5.52M
PE Ratio	133.70
Forward PE	65.59
Dividend	$0.64 (0.70%)
Ex-Dividend Date	Feb 27, 2026

Volume	59,210
Open	92.25
Previous Close	91.95
Day's Range	90.14 - 92.65
52-Week Range	55.45 - 154.26
Beta	0.89
Analysts	Hold
Price Target	94.00 (+3.35%)
Earnings Date	Feb 3, 2026

About MLAB

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the denta...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1982
• Employees: 730
• Stock Exchange: NASDAQ
• Ticker Symbol: MLAB
• Website: https://www.mesalabs.com

Financial Performance

In fiscal year 2025, Mesa Laboratories's revenue was $240.98 million, an increase of 11.47% compared to the previous year's $216.19 million. Losses were -$1.97 million, -99.22% less than in 2024.

Analyst Summary

According to one analyst, the rating for MLAB stock is "Hold" and the 12-month stock price target is $94.0.

Price Target

$94.0

(3.35% upside)

Analyst Consensus: Hold